BioSpace News Archive

Magnolia Medical Technologies, Inc. (“Magnolia Medical”) today announced it filed a motion for permanent injunction in the U.S. District Court for the District of Delaware on September 9, 2022, that would prohibit Kurin, Inc. (“Kurin”) from the continued sale of the infringing Kurin Lock products.

JenCare, a leading national provider of primary care to underserved, Medicare-eligible seniors, announced today the appointment of industry veteran Steve Nelson as CEO of JenCare.

The global nutrigenomics market size is expected to reach USD 1,289.7 Million in 2028 and register a steady revenue CAGR over the forecast period, according to latest analysis by Emergen Research.

The latest market analysis report published by Reports and Data, titled ‘Global Post-Menopausal Osteoporosis Market – Forecast to 2030,’ thoroughly examines the Post-Menopausal Osteoporosis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Hyperthyroidism Market – Forecast to 2030,’ thoroughly examines the Hyperthyroidism industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Autoimmune Hepatitis Market – Forecast to 2030,’ thoroughly examines the Autoimmune Hepatitis industry to provide essential data & information for the targeted readers.

LAVATherapeuticsN.V. (Nasdaq:LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers to transform the treatment of cancer, today announced recent corporate highlights and financial results for the second quarter ended June 30, 2022.

POINT Biopharma Global Inc. announced that it has commenced an underwritten public offering of its common stock.

McKesson Corporation announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer.

Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), announces it will highlight new product innovations at the 2022 American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Quebec City, Canada from September 14-17.